SmartWall ONE™ Relied Upon by Tier-1 Operators to Protect High-Capacity Networks and Enable DDoS Protection-as-a-Service

LONDON, Jan. 29, 2026 /PRNewswire/ — Corero Network Security (AIM: CNS) (OTCQX: DDOSF), a recognized leader in DDoS protection and champion of adaptive, real-time service availability, today announced two significant wins with Tier-1 telecommunications operators in the Asia-Pacific (APAC) region. The wins reflect growing demand for automated DDoS protection that ensures business continuity, safeguards customer experience, and enables new security services.

“As networks scale, Tier-1 operators are turning to Corero because our DDoS protection is built to perform at the highest levels,” said Carl Herberger, CEO at Corero Network Security. “We help service providers protect massive network capacity, differentiate their services, and deliver always-on security their customers can trust.”

Two Tier-1 telecommunications operators in APAC, both with global operations, are relying on Corero to ensure continuous service availability as their networks scale. One operator is using Corero to protect network capacity of up to 500Gbps, while the other is leveraging Corero to strengthen its security portfolio and deliver DDoS Protection-as-a-Service. Together, these wins help service providers keep customers connected while turning DDoS protection into a differentiated, revenue-generating service.

Across both wins, SmartWall ONE was relied upon to:

• Ensure continuous connectivity and service quality during large-scale DDoS attacks
• Detect and mitigate threats automatically and in real time
• Scale efficiently to support rapid network growth while lowering total cost of ownership
• Enable DDoS Protection-as-a-Service offerings for enterprise and consumer customers

By enabling always-on protection at scale, Corero helps Tier-1 operators keep customers online and secure—even during attack events—while strengthening trust, reducing churn risk, and unlocking new security-driven revenue. These wins reinforce Corero’s expanding footprint in APAC, a strategic growth region where operators are investing in resilience, automation, and differentiated services to support digital economies at scale.

About Corero Network Security
Corero Network Security is a leading provider of DDoS protection solutions, specializing in automatic detection and protection solutions with network visibility, analytics, and reporting tools. Corero’s technology protects against external and internal DDoS threats in complex edge and subscriber environments, ensuring internet service availability. With operational centers in Marlborough, Massachusetts, USA, and Edinburgh, UK, Corero is headquartered in London and listed on the London Stock Exchange’s AIM market (ticker: CNS) and the US OTCQX Market (OTCQX: DDOSF).

MELBOURNE, Australia, Jan. 29, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient has been dosed in the Phase 3 registration study of TLX591-Px (Illuccix®, Kit for the preparation of ⁶⁸Ga-PSMA-11) for prostate cancer imaging in Japanese patients. The patient was dosed at Shonan Kamakura General Hospital (SKGH) in Kamakura, Japan.

Illuccix Japan^[1] is a Phase 3 prospective, open-label, multicenter study designed to evaluate the detection efficacy and safety profile of ⁶⁸Ga-PSMA-11 PET/CT^[2] in Japanese patients with biochemically recurrent (BCR) prostate cancer following prior radical prostatectomy. The study will enroll up to 105 Japanese men at 11 sites and data are intended to support a future marketing authorization application for TLX591-Px in Japan.

The primary objective of the study is to compare the sensitivity of ⁶⁸Ga-PSMA-11 PET/CT to conventional imaging (CT and bone scintigraphy) for the detection of metastatic lesions. Secondary objectives include evaluating diagnostic performance for local and distant lesions, safety and tolerability, and the impact of ⁶⁸Ga-PSMA-11 PET/CT on clinical management decisions.

Commencement of the trial augments Telix’s early access and clinical activities in the world’s second-largest market for nuclear medicine. This includes compassionate use for TLX591-Px in Japan^[3], and the Phase 3 ProstACT Global study of TLX591-Tx (lutetium (¹⁷⁷Lu) rosopatamab tetraxetan)^[4] in advanced prostate cancer, which is now open for enrollment^[5].

Dr. David N. Cade, Telix Group Chief Medical Officer, commented, “PSMA-PET^[6] imaging has fundamentally changed how we detect and manage prostate cancer, providing greater accuracy and confidence in treatment planning compared with conventional imaging. Yet, access remains limited in much of Japan, where ⁶⁸Ga-PSMA-11 is not fully validated in the local clinical setting or across all stages of the disease. This milestone, together with Telix’s existing compassionate use supply to address unmet patient need, brings us significantly closer to improving access to gallium-based PSMA-PET and improving outcomes for men living with prostate cancer in Japan.”

About Prostate Cancer in Japan

The Asia Pacific region comprises approximately one-third of the world’s male population and includes many nations whose populations are ageing or increasingly adopting a more affluent, ‘Western-style’ lifestyle, the two main demographic trends driving increasing cancer incidence rates. Consequently, the incidence of prostate cancer is increasing in many parts of the region.

Prostate cancer is the most common cancer in Japanese men with more than 104,000 new diagnoses each year, and the sixth leading cause of cancer-related death with over 14,000 deaths annually^[7].

About Telix Pharmaceuticals Limited

Telix is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. Telix is headquartered in Melbourne, Australia, with international operations in the United States, United Kingdom, Brazil, Canada, Europe (Belgium and Switzerland), and Japan. Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (NASDAQ: TLX).

TLX591-Px (Illuccix®), Telix’s first generation PSMA-PET imaging agent, has been approved in multiple markets globally, excluding in Japan where use is investigational only.

Visit www.telixpharma.com or jp.telixpharma.com for further information about Telix, including details of the latest share price, ASX and U.S. Securities and Exchange Commission (SEC) filings, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on LinkedIn, X and Facebook.

Telix Investor Relations

Ms. Kyahn Williamson
Telix Pharmaceuticals Limited
SVP Investor Relations and Corporate Communications
Email: kyahn.williamson@telixpharma.com

Legal Notices

Cautionary Statement Regarding Forward-Looking Statements. 

You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our Annual Report on Form 20-F filed with the SEC, or on our website.

The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification.  To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement.

This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as “may”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “outlook”, “forecast” and “guidance”, or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix’s good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix’s business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix’s business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress, completion and results of Telix’s preclinical and clinical trials, and Telix’s research and development programs; Telix’s ability to advance product candidates into, enroll and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix’s product candidates, including the planned NDA resubmission for TLX101-Px and the planned BLA resubmission for TLX250-Px, manufacturing activities and product marketing activities; Telix’s sales, marketing and distribution and manufacturing capabilities and strategies; the commercialization of Telix’s product candidates, if or when they have been approved; Telix’s ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix’s expenses, future revenues and capital requirements; Telix’s financial performance; developments relating to Telix’s competitors and industry; the anticipated impact of U.S. and foreign tariffs and other macroeconomic conditions on Telix’s business; and the pricing and reimbursement of Telix’s product candidates, if and after they have been approved. Telix’s actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements.

Trademarks and Trade Names. All trademarks and trade names referenced in this press release are the property of Telix Pharmaceuticals Limited (Telix) or, where applicable, the property of their respective owners. For convenience, trademarks and trade names may appear without the ® or ™ symbols. Such omissions are not intended to indicate any waiver of rights by Telix or the respective owners. Trademark registration status may vary from country to country. Telix does not intend the use or display of any third-party trademarks or trade names to imply any affiliation with, endorsement by, or sponsorship from those third parties.

©2026 Telix Pharmaceuticals Limited. All rights reserved.

MELBOURNE, Australia, Jan. 29, 2026 /PRNewswire/ — Amid heightened volatility on the ASX, CFD traders are navigating conditions where blue-chip equities are beginning to exhibit price swings more commonly seen in commodities and indices. Mitrade’s latest strategic outlook, “Financial Markets 2026: Volatility Catalysts in Gold, Silver, Oil, and Blue-Chip Stocks—A CFD Trader’s Outlook“ examines the macroeconomic and cross-asset catalysts driving this repricing and what they may signal for traders positioning into 2026.

The report identifies three interconnected forces reshaping market behaviour: central bank policy uncertainty, geopolitical tensions fuelling demand for safe-haven assets, and competing dynamics within global energy markets—including rising AI infrastructure demand driving industrial inputs. These catalysts are already influencing the ASX today. On 19 January, the ASX 200 dipped 0.3%, with ABC News noting a sharp divergence—tech and bank stocks fell while utilities gained—signalling the broader repricing now affecting blue chip stocks Australia-wide.

“For Australian CFD traders, blue chip stocks offer a more accessible way to engage with market volatility—especially when compared to assets like gold, which often require higher entry capital,” said Elven Jong, CEO of Mitrade Australia. “What we’re seeing is that traditional equities are moving more like macro assets. That shift demands more than just access—it calls for context. Mitrade supports traders with a complete ecosystem that includes risk education, live market insights, and cross-device access to help traders stay connected when conditions shift rapidly.”

Viewed through a global lens, Mitrade’s report reflects broader shifts that are redefining how traders participate in today’s financial markets. Recognised for its commitment to transparency and innovation, Mitrade was named Best Trading Platform Australia 2025 and Best Forex Broker Australia. These accolades underscore the platform’s role in helping traders respond confidently to evolving market conditions.

About Mitrade
Mitrade is an award-winning CFD trading platform founded in Melbourne, trusted by 6M+ traders worldwide. It operates under top-tier financial regulators—Australia’s ASIC (AFSL398528), Cyprus’ CySEC (CIF438/23), the Cayman Islands’ CIMA (SIB1612446), South Africa’s FSCA (54842), and Mauritius’s FSC (GB20025791)—delivering a secure, seamless, and intuitive trading experience.

The platform provides 900+ CFDs on indices, forex, commodities, ETFs, and shares. Mitrade redefines trading with millisecond-execution, razor-thin spreads, robust risk management, and multi-device compatibility.

Trading involves risk. This article is for informational purposes only and does not constitute financial advice, an offer, or a solicitation.

Visit https://www.mitrade.com for more information.

SINGAPORE, Jan. 29, 2026 /PRNewswire/ — Radar Tyres, the flagship brand of Singapore-headquartered Omni United, is proud to announce that it has signed a strategic multi-year partnership with Cricket South Africa (CSA), becoming the Global Partner for the Proteas across all major formats.

As part of the agreement, Radar Tyres will hold Headline sponsorship rights for the Proteas Men’s and Women’s T20 International teams, Associate Partner for the Proteas Men’s and Women’s ODI and Test teams and Headline Partner of the Proteas Under-19 Men’s and Women’s teams.

The partnership delivers extensive on-field and off-field brand visibility, including exclusive logo placement on match and training kits. The Proteas Men revealed their newly branded T20I kit on 27th January in Paarl.

For Radar Tyres, the partnership represents a strategic brand building investment in a globally followed sport. With a growing presence across global markets, Radar continues to leverage high-impact platforms to strengthen brand equity while remaining focused on delivering premium-performance tyres at an accessible price point.

“Becoming the Global Partner of the Proteas marks a significant milestone in Radar Tyres’ global brand journey and reflects our belief in sport as a powerful platform to build brand equity, strengthen dealer support, enhance trust and credibility, and connect with households worldwide. Through this partnership, we are able to engage with cricket fans both locally and globally, while reinforcing Radar Tyres’ as a reliable, performance-driven brand committed to delivering premium-performance tyres at accessible price points.” Said G.S. Sareen, President and CEO, Omni United.

“CSA is extremely proud to partner with Radar Tyres, an organisation that shares our values and commitment to excellence. This partnership is a significant milestone, securing support not only for our senior teams but for our junior teams as well. This partnership reflects our deliberate approach to working with like-minded organisations, guided by a long-term vision of developing the game, supporting our players, and delivering memorable experiences for fans. Radar Tyres’ support also reinforces CSA’s commitment to excellence and inclusion, strengthening our ability to drive high performance across all levels.” Said Pholetsi Moseki, Chief Executive Officer, CSA. 

Radar Tyres are distributed in Australia by National Wheel & Tyre.

Official websites www.omni-united.com and www.radartyres.com

ABOUT RADAR TYRES:
Radar Tyres, the flagship brand of Singapore-headquartered Omni United, is a global tyre brand available in over 80 countries worldwide. The brand believes that everyone has the right to access top-quality, premium tyres at affordable prices. Radar Tyres are test-proven to deliver performance comparable to leading brands but without the premium price tag. Radar Tyres offers a tyres for all seasons and applications, covering passenger cars, SUVs, 4x4s, electric vehicles and commercial vehicles.

SINGAPORE, Jan. 29, 2026 /PRNewswire/ — Radar Tyres, the flagship brand of Singapore-headquartered Omni United, is proud to announce that it has signed a strategic multi-year partnership with Cricket South Africa (CSA), becoming the Global Partner for the Proteas across all major formats.

As part of the agreement, Radar Tyres has Headline sponsorship rights for the Proteas Men’s and Women’s T20 International teams, Associate Partner for the Proteas Men’s and Women’s ODI and Test teams and Headline Partner of the Proteas Under-19 Men’s and Women’s teams.

The partnership delivers extensive on-field and off-field brand visibility, including exclusive logo placement on match and training kits. The Proteas Men revealed their newly branded T20I kit on 27th January in Paarl.

For Radar Tyres, the partnership represents a strategic brand building investment in a globally followed sport. With a growing presence across global markets, Radar continues to leverage high-impact platforms to strengthen brand equity while remaining focused on delivering premium-performance tyres at an accessible price point.

“Becoming the Global Partner of the Proteas marks a significant milestone in Radar Tyres’ global brand journey and reflects our belief in sport as a powerful platform to build brand equity, strengthen dealer support, enhance trust and credibility, and connect with households worldwide. Through this partnership, we are able to engage with cricket fans both locally and globally, while reinforcing Radar Tyres’ position as a reliable, performance-driven brand committed to delivering premium-performance tyres at accessible price points.” Said G.S. Sareen, President and CEO, Omni United.

“CSA is extremely proud to partner with Radar Tyres, an organisation that shares our values and commitment to excellence. This partnership is a significant milestone, securing support not only for our senior teams but for our junior teams as well. This partnership reflects our deliberate approach to working with like-minded organisations, guided by a long-term vision of developing the game, supporting our players, and delivering memorable experiences for fans. Radar Tyres’ support also reinforces CSA’s commitment to excellence and inclusion, strengthening our ability to drive high performance across all levels.” Said Pholetsi Moseki, Chief Executive Officer, CSA.

Radar Tyres are distributed in New Zealand by YHI Limited.

Official websites www.omni-united.com and www.radartyres.com

ABOUT RADAR TYRES:

Radar Tyres, the flagship brand of Singapore-headquartered Omni United, is a global tyre brand available in over 80 countries worldwide. The brand firmly believes that everyone has the right to access top-quality, premium tyres at affordable prices. Radar Tyres are test-proven to deliver performance comparable to leading brands but without the premium price tag. Radar Tyres offers tyres for all seasons and applications, covering passenger cars, SUVs, 4x4s, electric vehicles and commercial vehicles. 

LOS ANGELES, Jan. 29, 2026 /PRNewswire/ — Spring weddings call for softness, movement, and a color palette that feels fresh yet timeless, and Azazie’s latest 2026 Bridesmaid Dress Collection delivers all three. Designed for modern bridal parties who want cohesive style without sacrificing individuality, Azazie’s Spring lineup blends romantic silhouettes, elevated fabrics, and inclusive sizing into a shopping experience that’s as seamless as it is stylish.

From garden ceremonies to destination “I do’s,” Azazie’s Spring bridesmaid dresses are rooted in versatility. Lightweight chiffons float effortlessly down the aisle, stretch satin styles bring a polished edge, and floral burnout fabrics add subtle texture that feels perfectly in step with the season. The result? A collection that looks curated – never cookie-cutter.

A Palette That Works for Every Vision
With more than 90 color options to choose from, Azazie makes it easy for brides to bring their vision to life, whether that means soft pastels, nature-inspired greens, or classic neutrals. The brand’s signature mix-and-match approach allows bridesmaids to select silhouettes they genuinely love while maintaining a cohesive look across the bridal party – a balance that feels both modern and effortless.

Flattering Fits for Every Body
Inclusivity remains at the core of Azazie’s design philosophy. Every bridesmaid dress in the Spring collection is available in sizes 00–30, with custom sizing offered at no additional cost. It’s a detail that continues to resonate with bridal parties, ensuring every bridesmaid feels confident, comfortable, and fully herself on the wedding day.

Spring Standouts Brides Are Loving
The collection highlights flowing A-line gowns with flutter sleeves, romantic off-the-shoulder silhouettes, sleek one-shoulder styles, and even tea-length options for brides seeking a more relaxed (but equally elevated) aesthetic. Thoughtful details like hidden pockets, adjustable straps, and easy-to-wear fabrics prove that style and practicality can coexist beautifully.

Perhaps most compelling? Azazie’s approach allows bridesmaids to find dresses they’ll actually wear again. With accessible price points and timeless designs, it’s a win for the bridal party long after the wedding weekend ends.

For brides navigating the ever-evolving world of bridal fashion, Azazie’s Spring bridesmaid collection strikes the perfect balance: elevated, inclusive, and refreshingly stress-free; exactly what spring weddings are meant to feel like.

LOS ANGELES, Jan. 29, 2026 /PRNewswire/ — The Internet Corporation for Assigned Names and Numbers (ICANN) Nominating Committee (NomCom) is now accepting applications for the ICANN Board of Directors. New Board members will serve from ICANN’s 2026 Annual Meeting in October 2026 until its 2029 Annual Meeting.

ICANN plays a critical role in maintaining the secure and stable coordination of the Internet’s unique identifiers – ensuring that the single, interoperable Internet continues to serve more than six billion users worldwide. The ICANN Board of Directors provides strategic oversight, policy direction, and fiduciary governance for this global nonprofit organization, which has an annual operating budget of approximately $150 million and more than 450 staff members worldwide.

A Call for Business Leaders With a Global Outlook
The NomCom, tasked with filling two Board positions, is seeking applications from experienced business leaders who will bring fresh perspectives to the Board’s work. Individuals who have successfully operated in complex, international environments and understand the challenges of managing at scale are encouraged to apply.

Ideal candidates will possess Board experience in organizations of comparable size and scope to ICANN, coupled with a strong commitment to public service and global collaboration.

Who Should Apply
The NomCom seeks accomplished individuals who demonstrate:

• Integrity, Objectivity, and Strategic Thinking: Reputations for sound judgment, ethical leadership, and thoughtful decision-making.
• Executive Management Experience: Senior leadership roles in business or nonprofit organizations, ideally with enterprise-wide responsibility for governance, finance, strategy, or risk management.
• Nonprofit Board Experience: Familiarity with fiduciary accountability, consensus-building, and strategic oversight in mission-driven organizations.
• Knowledge of ICANN’s Role: Understanding of, or a strong interest in, the Internet’s infrastructure and ICANN’s mission within the global Internet ecosystem.
• Diversity and Cultural Awareness: Ability to work effectively across regions, languages, and cultural contexts; commitment to contributing to a diverse and globally representative Board.

While expertise in Internet technologies is valuable, it is not required; ICANN welcomes candidates from across industry sectors who can apply business discipline, strategic oversight, and governance best practices to a technical and policy-focused environment.

Commitment and Expectations
Board members devote approximately 20 hours per week to their ICANN responsibilities. The role includes participation in up to six Board workshops and three ICANN Public Meetings annually, ongoing Board committee and other Board group work, and engagement in the ICANN community across multiple time zones.

Why Business Leaders Should Consider This Opportunity
“Serving on the ICANN Board offers individuals a unique opportunity to apply their governance and strategic experience to the global public good,” said Tom Barrett, Chair of the ICANN Nominating Committee. “ICANN operates at the intersection of technology, policy, and international collaboration. Its Board members help guide a nonprofit organization’s decisions that affect the security, stability, and resilience of the Internet – a critical resource for the majority of governments, businesses, and individual users worldwide.”

“Strong governance experience from profit and nonprofit sectors strengthens ICANN’s ability to operate responsibly and effectively,” added James Gannon, Chair-elect of the ICANN Nominating Committee. “We are looking for leaders who understand both stewardship and collaboration.”

How to Apply
Detailed information about requirements, commitments, and expectations are available at the NomCom webpage. The application form is available on the dedicated webpage.

The deadline to submit an application is 18 February 2026.
The NomCom conducts all evaluations confidentially, in accordance with ICANN’s Bylaws and commitment to transparency and diversity. Successful candidates will be seated on the Board of Directors at ICANN’s 2026 Annual General Meeting in October 2026.

About ICANN
ICANN’s mission is to help ensure a stable, secure, and unified global Internet. To reach another person on the Internet, you need to type an address – a name or a number – into your computer or other device. That address must be unique so computers know where to find each other. ICANN helps coordinate and support these unique identifiers across the world. ICANN was formed in 1998 as a nonprofit public benefit corporation with a community of participants from all over the world. For more information, visit https://www.icann.org.